Moreover, in the analysis of the correlation between EGFR genotype and tumour stage, we observed that the proportion of EGFR mutation (Mut) patients and stage III/IV patients in the high‐score group was significantly higher than that in the low‐score group (Fisher p = 0.021 and p = 0.025, respectively). Here, EGFR is linked to neoplasm.